XENE - Xenon Pharmaceuticals Inc
This page shows which of the focused investors we track hold XENE and how their positions changed, so you can see how much conviction the group has in the stock.
In Q1 2026 it was held by 1 manager with an aggregate reported value of $13.88M, which is 0.00% of the combined portfolio.
As of Q1 2026, 1 tracked institutional manager held XENE (Xenon Pharmaceuticals Inc) with an aggregate reported value of $13.88M — 0.00% of the combined AlphaBaseline portfolio.
Get email alerts when a tracked manager trades XENE — sign in or create a free account.
- Source
- Curated SEC 13F filings
- Period
- Q1 2026
- Ticker
- XENE
13F data is delayed and excludes shorts/non-13F assets.
Holders
| 1 | Stanley Druckenmiller - Duquesne Family Office LLC | 0.47% | New | 238,600 | $13.88M |
Loading holder history for XENE…